Form 8-K - Current report:
SEC Accession No. 0001193125-25-121296
Filing Date
2025-05-16
Accepted
2025-05-16 07:54:33
Documents
18
Period of Report
2025-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833625d8k.htm   iXBRL 8-K 52452
2 EX-2.1 d833625dex21.htm EX-2.1 468212
3 EX-10.1 d833625dex101.htm EX-10.1 79645
4 EX-99.1 d833625dex991.htm EX-99.1 36377
8 GRAPHIC g916136dsp1a.jpg GRAPHIC 4610
9 GRAPHIC g916136dsp1b.jpg GRAPHIC 4856
  Complete submission text file 0001193125-25-121296.txt   927673

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20250516.xsd EX-101.SCH 2853
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20250516_lab.xml EX-101.LAB 17235
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20250516_pre.xml EX-101.PRE 10814
21 EXTRACTED XBRL INSTANCE DOCUMENT d833625d8k_htm.xml XML 3531
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 25956953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)